CpG DNA as mucosal adjuvant

Vaccine

Volumn 18, Issue 3-4, 1999, Pages 231-237

  McCluskie, Michael J ^a,b   Davis, Heather L ^a,b,c  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b University of   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Lung; Mucosal; Vaccination

Indexed keywords

ADJUVANT; CHOLERA TOXIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; OLIGODEOXYNUCLEOTIDE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; CYTOSINE; DNA; FEMALE; GUANINE; HEPATITIS B SURFACE ANTIGENS; IMMUNIZATION, SECONDARY; MICE; MICE, INBRED BALB C; MUCOUS MEMBRANE;

EID: 0032876565     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00194-2     Document Type: Conference Paper

References (38)

1. Haneberg B., Kendall D., Amerongen H.M., Apter F.M., Kraehenbuhl J.P., Neutra M.R. Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces. Infect. Immun. 62:1994;15-23.
2. Gallichan W.S., Rosenthal K.L. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine. 13:1995;1589-1595.
3. Rappuoli R., Douce G., Dougan G., Pizza M. Genetic detoxification of bacterial toxins: a new approach to vaccine development. Int. Arch. Allergy Immunol. 108:1995;327-333.
4. Fontana M.R., Manetti R., Giannelli V., Magagnoli C., Marchini A., Olivieri R., Domenighini M., Rappuoli R., Pizza M. Construction of nontoxic derivatives of cholera toxin and characterization of the immunological response against the A subunit. Infect. Immun. 63:1995;2356-2360.
5. Tokunaga T., Yano O., Kuramoto E., Kimura Y., Yamamoto T., Kataoka T., Yamamoto S. Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol. Immunol. 36:1992;55-66.
6. Messina J.P., Gilkeson G.S., Pisetsky D.S. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol. 147:1991;1759-1764.
7. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G., Klinman D. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature. 374:1995;546-549.
8. Krieg A.M. An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA. J. Lab. Clin. Med. 128:1996;128-133.
9. Yi A.K., Klinman D.M., Martin T.L., Matson S., Krieg A.M. Rapid immune activation by CpG motifs in bacterial DNA. Systemic induction of IL-6 transcription through an antioxidant-sensitive pathway. J. Immunol. 157:1996;5394-5402.
10. Yi A.K., Hornbeck P., Lafrenz D.E., Krieg A.M. CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xL. J. Immunol. 157:1996;4918-4925.
11. Klinman D., Yi A.K., Beaucage S.L., Conover J., Krieg A.M. CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFN-γ Proc. Natl. Acad. Sci. USA. 93:1996;2879-2883.
12. Halpern M.D., Kurlander R.J., Pisetsky D.S. Bacterial DNA induces murine interferon-γ production by stimulation of interleukin-12 and tumor necrosis factor-α Cell. Immunol. 167:1996;72-78.
13. Cowdery J.S., Chace J.H., Krieg A.M. Bacterial DNA induces in vivo interferon-γ production by NK cells and increases sensitivity to endotoxin. J. Immunol. 156:1996;4570-4575.
14. Schwartz D.A., Quinn T.J., Thorne P.S., Sayeed S., Yi A.K., Krieg A.M. CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract. J. Clin. Invest. 100:1997;68-73.
15. Yamamoto S., Yamamoto T., Shimada S., Kuramoto E., Yano O., Kataoka T., Tokunaga T. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol. Immunol. 36:1992;983-997.
16. Ballas Z.K., Rasmussen W.L., Krieg A.M. Induction of natural killer activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157:1996;1840-1845.
17. Chace J.H., Hooker N.A., Mildenstein K.L., Krieg A.M., Cowdery J.S. Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin. Immunol. Immunopath. 84:1997;185-193.
18. Yi A.K., Chace J.H., Cowdery J.S., Krieg A.M. IFN-γ promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides. J. Immunol. 156:1996;558-564.
19. Roman M., Martin-Orozco E., Goodman J.S., Nguyen M.D., Sato Y., Ronaghy A., Kornbluth R.S., Richman D.D., Carson D.A., Raz E. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3:1997;849-854.
20. Davis H.L., Weeratna R., Waldschmidt T.J., Schorr J., Krieg A.M. CpG DNA is a potent adjuvant in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160:1998;870-876.
21. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186:1997;1623-1631.
22. Lipford G.B., Sparwasser T., Bauer M., Zimmermann S., Koch E.S., Heeg K., Wagner H. Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines. Eur. J. Immunol. 27:1997;3420-3426.
23. Weiner G.J., Liu H.M., Wooldridge J.E., Dahle C.E., Krieg A.M. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc. Natl. Acad. Sci. USA. 94:1997;10833-10837.
24. Sun S., Kishimoto H., Sprent J. DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J. Exp. Med. 187:1998;1145-1150.
25. Moldoveanu Z., Love-Homan L., Huang W.Q., Krieg A.M. CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus. Vaccine. 16:1998;1216-1224.
26. McCluskie M.J., Davis H.L. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J. Immunol. 161:1998;4463-4466.
27. Takahashi I., Marinaro M., Kiyono H., Jackson R.J., Nakagawa I., Fujihashi K., Hamada S., Clements J.D., Bost K.L., McGhee J.R. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J. Infect. Dis. 173:1996;627-635.
28. Munoz E., Zubiaga A.M., Merrow M., Sauter N.P., Huber B.T. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J. Exp. Med. 172:1990;95-103.
29. Yamamoto S., Kiyono H., Yamamoto M., Imaoka K., Fujihashi K., Van Ginkel F.W., Noda M., Takeda Y., McGhee J.R. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA. 94:1990;5267-5272.
30. Snider D.P. The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins. Crit. Rev. Immunol. 15:1995;317-348.
31. Ramsay A.J., Husband A.J., Ramshaw I.A., Bao S., Matthaei K.I., Koehler G., Kopf M. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science. 264:1994;561-563.
32. Marinaro M., Boyaka P.N., Finkelman F.D., Kiyono H., Jackson R.J., Jirillo E., McGhee J.R. Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J. Exp. Med. 185:1997;415-427.
33. Marinaro M., Boyaka P.N., Jackson R.J., Finkelman F.D., Kiyono H., McGhee J.R. Interleukin-12 alters helper T-cell subsets and antibody profiles induced by the mucosal adjuvant cholera toxin. Ann. NY Acad. Sci. 795:1996;361-365.
34. Tomkiewicz R.P., Albers G.M., De Sanctis G.T., Ramirez O.E., King M., Rubin B.K. Species differences in the physical and transport properties of airway secretions. Can. J. Physiol. Pharmacol. 73:1995;165-171.
35. Hazinski T.A. Gene transfection of lung cells in vitro and in vivo. Annu. Rev. Physiol. 55:1993;181-207.
36. Bernstein J.M., Yamanaka N., Nadal D. Immunobiology of the tonsils and adenoids. Ogra P.L. Handbook of mucosal immunity. 1994;625-640 Academic Press, Inc, San Diego.
37. Kuper C.F., Koornstra P.J., Hameleers D.M., Biewenga J., Spit B.J., Duijvestijn A.M., van Breda Vriesman P.J., Sminia T. The role of nasopharyngeal lymphoid tissue. Immunol. Today. 13:1992;219-224.
38. Wu H.Y., Nguyen H.H., Russell M.W. Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand. J. Immunol. 46:1997;506-513.